✦ LIBER ✦

Bevacizumab demonstrates activity in advanced refractory fallopian tube carcinoma

✍ Scribed by N. ARORA; D. TEWARI; C. COWAN; B. SAFFARI; B.J. MONK; R.A. BURGER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab and weekly taxane chemothera

✍ David E. Cohn; Sue Valmadre; Kimberly E. Resnick; Lynne A. Eaton; Larry J. Copel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Results of chemotherapy in advanced carc

✍ William A. Peters III; Willie A. Andersen; Michael P. Hopkins 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Bevacizumab shows activity in advanced r

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Activity of bevacizumab (rhuMAB VEGF) in

✍ Bradley J. Monk; David C. Choi; Gordon Pugmire; Robert A. Burger 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Outcome differences in patients with adv

✍ Randall, L.; Burger, R.; Nguyen, H.; Kong, G.; Bookman, M.; Fleming, G.; Monk, B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Primary carcinoma of the fallopian tube:

✍ W.Z. Maxson; F.B. Stehman; T.M. Ulbright; G.P. Sutton; C.E. Ehrlich 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 177 KB